Gene · 55165
Papers1,450
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,450
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of shared biomarkers and drug repurposing in psoriasis and Crohn's disease: integrating bioinformatics, machine learning, and experimental approaches. | Front Immunol | 2025 | 40406126 | PubTator, text mining | PubMed |
| CEP55 as a prognostic indicator and a predictive marker in oral squamous cell carcinoma. | Int J Med Sci | 2025 | 40386043 | PubTator, text mining | PubMed |
| A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision. | Int J Biol Macromol | 2025 | 40306500 | PubTator, text mining | PubMed |
| UBTD2 protein molecules emerges as a key prognostic protein marker in glioma: Insights from integrated omics and machine learning analysis of GRM7, NCAPG, CEP55, and other biomarkers. | Int J Biol Macromol | 2025 | 40286967 | PubTator, text mining | PubMed |
| Clinical potential and experimental validation of prognostic genes in hepatocellular carcinoma revealed by risk modeling utilizing single cell and transcriptome constructs. | Front Immunol | 2025 | 40255404 | PubTator, text mining | PubMed |
| CEP55, A Promising Prognostic Biomarker for Pancreatic Neuroendocrine Neoplasms, Promotes Tumor Progression Through Activation of PI3K/AKT/mTOR Pathway. | FASEB J | 2025 | 40249668 | PubTator, text mining | PubMed |
| iMLGAM: Integrated Machine Learning and Genetic Algorithm-driven Multiomics analysis for pan-cancer immunotherapy response prediction. | Imeta | 2025 | 40236779 | PubTator, text mining | PubMed |
| Reply to: Do actin isoforms have unique functionalities at the protein level? | Nat Commun | 2025 | 40055314 | PubTator, text mining | PubMed |
| NEMO Family of Proteins as Polyubiquitin Receptors: Illustrating Non-Degradative Polyubiquitination's Roles in Health and Disease. | Cells | 2025 | 39996775 | PubTator, text mining | PubMed |
| Mechanism of Centrosomal Protein 55 (CEP55) Loading Into Exosomes. | J Extracell Vesicles | 2025 | 39976236 | PubTator, text mining | PubMed |
| Cross-talk between lactate metabolism and immunity reveals CEP55 as a potential regulator in the immunosuppressive microenvironment of hepatocellular carcinoma. | Genes Dis | 2025 | 39911798 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. | Curr Genomics | 2025 | 39911278 | PubTator, text mining | PubMed |
| RNA binding protein ILF3 increases CEP55 mRNA stability to enhance malignant potential of breast cancer cells and suppress ferroptosis. | Hereditas | 2025 | 39871389 | PubTator, text mining | PubMed |
| Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID-19 Infection. | Immun Inflamm Dis | 2025 | 39853911 | PubTator, text mining | PubMed |
| Study of urine-based mRNA biomarkers for early detection of nonmuscle invasive bladder cancer (NMIBC). | Urol Oncol | 2025 | 39800632 | PubTator, text mining | PubMed |
| Biallelic missense CEP55 variants cause prenatal MARCH syndrome. | J Hum Genet | 2025 | 39414989 | PubTator, text mining | PubMed |
| Molecular and mechanical mechanisms of animal cell abscission. | FEBS Lett | 2025 | 39324548 | PubTator, text mining | PubMed |
| LINCRNA01094 Promotes Renal Interstitial Fibrosis via the Mir-513b-5p/ MELK/Smad3 Axis. | Endocr Metab Immune Disord Drug Targets | 2025 | 39318012 | PubTator, text mining | PubMed |
| Prognostic assessment value of immune escape-related genes in patients with acute myeloid leukemia. | Leuk Lymphoma | 2025 | 39311489 | PubTator, text mining | PubMed |
| CEP55: Implications for Immunotherapy and Survival in Hepatocellular Carcinoma. | Comb Chem High Throughput Screen | 2025 | 38847172 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55165/papers?page=4